Next Science NXSCF Stock
Next Science Price Chart
Next Science NXSCF Financial and Trading Overview
| Next Science stock price | 0.0010 USD |
| Previous Close | 1.2574071E-27 USD |
| Open | 0.02 USD |
| Bid | 0.001 USD x 1000000 |
| Ask | 0.16 USD x 1000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.0002 - 0.11 USD |
| Volume | 20K USD |
| Avg. Volume | 4.23K USD |
| Market Cap | 334.88K USD |
| Beta (5Y Monthly) | 1.692 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | February 2, 2026 |
| 1y Target Est | N/A |
NXSCF Valuation Measures
| Enterprise Value | 4.62M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.015174217 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.209 |
| Enterprise Value/EBITDA | -0.563 |
Trading Information
Next Science Stock Price History
| Beta (5Y Monthly) | 1.692 |
| 52-Week Change | -98.82% |
| S&P500 52-Week Change | 31.40% |
| 52 Week High | 0.11 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.06 USD |
NXSCF Share Statistics
| Avg. Volume (3 month) | 4.23K USD |
| Avg. Daily Volume (10-Days) | 7.09K USD |
| Shares Outstanding | 292.63M |
| Float | 139.25M |
| Short Ratio | N/A |
| % Held by Insiders | 51.90% |
| % Held by Institutions | 8.02% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -42.73% |
| Operating Margin (ttm) | -41.22% |
| Gross Margin | 82.48% |
| EBITDA Margin | -37.23% |
Management Effectiveness
| Return on Assets (ttm) | -50.99% |
| Return on Equity (ttm) | -289.69% |
Income Statement
| Revenue (ttm) | 22.07M USD |
| Revenue Per Share (ttm) | 0.08 USD |
| Quarterly Revenue Growth (yoy) | -6.70% |
| Gross Profit (ttm) | 18.2M USD |
| EBITDA | -8217634 USD |
| Net Income Avi to Common (ttm) | -9431461 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 971.24K USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 5.3M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.377 |
| Book Value Per Share (mrq) | -0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5709115 USD |
| Levered Free Cash Flow (ttm) | -3536223 USD |
Profile of Next Science
| Country | United States |
| State | NSW |
| City | Sydney |
| Address | Australia Square |
| ZIP | 2000 |
| Phone | 61 4 1229 2977 |
| Website | https://www.nextscience.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.
Q&A For Next Science Stock
What is a current NXSCF stock price?
Next Science NXSCF stock price today per share is 0.0010 USD.
How to purchase Next Science stock?
You can buy NXSCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Next Science?
The stock symbol or ticker of Next Science is NXSCF.
Which industry does the Next Science company belong to?
The Next Science industry is Drug Manufacturers - Specialty & Generic.
How many shares does Next Science have in circulation?
The max supply of Next Science shares is 334.88M.
What is Next Science Price to Earnings Ratio (PE Ratio)?
Next Science PE Ratio is 0.00000000 now.
What was Next Science earnings per share over the trailing 12 months (TTM)?
Next Science EPS is 0 USD over the trailing 12 months.
Which sector does the Next Science company belong to?
The Next Science sector is Healthcare.